Cargando…

Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases

Regucalcin is a soluble protein that is principally expressed in hepatocytes. Studies of regucalcin have mainly been conducted in animals due to a lack of commercially available kits. We aimed to develop an enzyme-linked immunosorbent assay (ELISA) to quantify serum regucalcin in patients with hepat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xinhuan, Yu, Haibin, Zhao, Peng, Xie, Li, Li, Li, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774222/ https://www.ncbi.nlm.nih.gov/pubmed/31576907 http://dx.doi.org/10.1590/1414-431X20198845

Ejemplares similares

Exogenous regucalcin negatively regulates the progression of cervical adenocarcinoma
por: Li, Xiaolong, et al.
Publicado: (2019)

Detection of Hepatitis B virus in serum and liver of chickens
por: Tian, Jijing, et al.
Publicado: (2012)

Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy
por: Wei, Xinhuan, et al.
Publicado: (2017)

Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
por: Arain, Sadia Qamar, et al.
Publicado: (2018)

The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways
por: Yamaguchi, Masayoshi
Publicado: (2013)

Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B
por: SHEN, HONG-HUI, et al.
Publicado: (2015)

Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection
por: Zhang, Lu, et al.
Publicado: (2017)

Hepatitis D virus and liver transplantation: Indications and outcomes
por: Muhammad, Haris, et al.
Publicado: (2021)

Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection
por: Wang, Yin-Qiu, et al.
Publicado: (2018)

Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells
por: Yamaguchi, Masayoshi, et al.
Publicado: (2020)

Immune-mediated Liver Injury in Hepatitis B Virus Infection
por: Oh, In Soo, et al.
Publicado: (2015)

Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure
por: Xiao, Lanlan, et al.
Publicado: (2021)

Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury
por: Mao, WeiLin, et al.
Publicado: (2015)

Regulatory role of regucalcin in heart calcium signaling: Insight into cardiac failure (Review)
por: YAMAGUCHI, MASAYOSHI
Publicado: (2014)

Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy
por: Yamaguchi, Masayoshi
Publicado: (2023)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure
por: Yang, Luo, et al.
Publicado: (2022)

Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure
por: CHEN, HONG-MEI, et al.
Publicado: (2014)

High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure
por: Zhou, Chao, et al.
Publicado: (2020)

Liver volume based prediction model for patients with hepatitis B virus‐related acute‐on‐chronic liver failure
por: Hu, Chunhua, et al.
Publicado: (2022)

The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection
por: Liu, Changjiang, et al.
Publicado: (2018)

Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
por: Wu, Cheng, et al.
Publicado: (2015)

Regucalcin confers resistance to amyloid‐β toxicity in neuronally differentiated PC12 cells
por: Murata, Tomiyasu, et al.
Publicado: (2018)

Regucalcin enhances adipocyte differentiation and attenuates inflammation in 3T3‐L1 cells
por: Murata, Tomiyasu, et al.
Publicado: (2020)

Platelet count is closely associated with the severity of liver injury in patients with chronic hepatitis B virus infection: A cross-sectional study
por: Yang, Ya-Ting, et al.
Publicado: (2020)

Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
por: Zhu, Bingbing, et al.
Publicado: (2023)

Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models
por: Dong, Huimin, et al.
Publicado: (2022)

Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure
por: Cao, Zhujun, et al.
Publicado: (2015)

The Immune Landscape of Hepatitis B Virus-Related Acute Liver Failure by Integration Analysis
por: Gong, Jiao, et al.
Publicado: (2022)

Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
por: Liu, Huimin, et al.
Publicado: (2020)

Factors Prognostic of Survival in Liver Transplant Recipients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Zhou, Zhengjun, et al.
Publicado: (2022)

N-glycopeptide Signatures of IgA(2) in Serum from Patients with Hepatitis B Virus-related Liver Diseases
por: Zhang, Shu, et al.
Publicado: (2019)

A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells
por: Li, Xiaolong, et al.
Publicado: (2019)

The Plasma S-adenosylmethionine Level is Associated With the Severity of Hepatitis B-Related Liver Disease
por: Li, Ting, et al.
Publicado: (2015)

Liver injury changes the biological characters of serum small extracellular vesicles and reprograms hepatic macrophages in mice
por: Lv, Xiu-Fang, et al.
Publicado: (2021)

Effects of Hepatitis B Virus Mutations on its Replication and Liver Disease Severity
por: Hakami, Abdulrahim, et al.
Publicado: (2013)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population
por: Sun, Yifan, et al.
Publicado: (2015)

Two cases reports: Severe liver injury caused by 1,2,3-trichloropropane poisoning
por: Li, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aptvedks507ecffk2ub84mpq74